Fused dihydrofurans as GPR119 modulators for the treatment of diabetes, obesity and related disorders

摘要

The present invention relates to compounds of general formula I, wherein the groups R1, LP, LQ, X1, X2, X3, A, n and m are as defined in the application. The compounds of formula I have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.